Free Trial
NYSE:SYK

Stryker (SYK) Stock Price, News & Analysis

Stryker logo
$294.49 +2.16 (+0.74%)
Closing price 03:59 PM Eastern
Extended Trading
$295.80 +1.31 (+0.45%)
As of 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Stryker Stock (NYSE:SYK)

Advanced

Key Stats

Today's Range
$292.48
$298.73
50-Day Range
$292.13
$387.53
52-Week Range
$289.91
$404.87
Volume
2.65 million shs
Average Volume
2.31 million shs
Market Capitalization
$112.78 billion
P/E Ratio
34.08
Dividend Yield
1.20%
Price Target
$395.48
Consensus Rating
Moderate Buy

Company Overview

Stryker Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
96th Percentile Overall Score

SYK MarketRank™: 

Stryker scored higher than 96% of companies evaluated by MarketBeat, and ranked 27th out of 860 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Stryker has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on no strong buy ratings, 16 buy ratings, 6 hold ratings, and no sell ratings.

  • Upside Potential

    Stryker has a consensus price target of $395.48, representing about 34.3% upside from its current price of $294.49.

  • Amount of Analyst Coverage

    Stryker has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Stryker's stock forecast and price target.
  • Earnings Growth

    Earnings for Stryker are expected to grow by 11.01% in the coming year, from $14.98 to $16.63 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Stryker is 34.08, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 42.46.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Stryker is 34.08, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.22.

  • Price to Earnings Growth Ratio

    Stryker has a PEG Ratio of 1.84. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Stryker has a P/B Ratio of 4.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.29% of the float of Stryker has been sold short.
  • Short Interest Ratio / Days to Cover

    Stryker has a short interest ratio ("days to cover") of 2.63, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Stryker has recently increased by 6.86%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Stryker pays a meaningful dividend of 1.20%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Stryker has been increasing its dividend for 32 years.

  • Dividend Coverage

    The dividend payout ratio of Stryker is 40.74%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Stryker will have a dividend payout ratio of 21.17% next year. This indicates that Stryker will be able to sustain or increase its dividend.

  • Read more about Stryker's dividend.
  • News Sentiment

    Stryker has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 55 news articles for Stryker this week, compared to 9 articles on an average week.
  • Search Interest

    40 people have searched for SYK on MarketBeat in the last 30 days. This is an increase of 11% compared to the previous 30 days.
  • MarketBeat Follows

    15 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Stryker insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    4.60% of the stock of Stryker is held by insiders.

  • Percentage Held by Institutions

    77.09% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Stryker's insider trading history.
Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SYK Stock News Headlines

Stryker declares an $0.88 per share quarterly dividend
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it coming — but those who did walked away wealthy.Trump holds that same legal authority today. Advisors close to the administration believe he may use it.If he does, the transfer moves fast. The window to position yourself on the right side is already closing.tc pixel
Bernstein Reaffirms Their Buy Rating on Stryker (SYK)
See More Headlines

SYK Stock Analysis - Frequently Asked Questions

Stryker's stock was trading at $351.28 at the start of the year. Since then, SYK shares have decreased by 16.2% and is now trading at $294.49.

Stryker Corporation (NYSE:SYK) released its quarterly earnings data on Thursday, April, 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by $0.38. The firm's quarterly revenue was up 2.6% compared to the same quarter last year.
Read the conference call transcript
.

Stryker subsidiaries include Vocera Communications, Vocera, Gauss Surgical, OrthoSensor, Wright Medical Group, Cardan Robotics, Mobius Imaging, and others.

Stryker's top institutional shareholders include Bank of New York Mellon Corp (1.03%), Dimensional Fund Advisors LP (0.32%), Swiss National Bank (0.26%) and Sumitomo Mitsui Trust Group Inc. (0.20%). Insiders that own company stock include Ronda E Stryker, Kevin Lobo, Allan C Golston, Viju Menon, M Kathryn Fink, Preston Wendell Wells, Srikant M Datar, Glenn S Boehnlein and William E Berry Jr.
View institutional ownership trends
.

Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stryker investors own include Broadcom (AVGO), ServiceNow (NOW), BlackRock (BLK), NVIDIA (NVDA), Meta Platforms (META), UnitedHealth Group (UNH) and Advanced Micro Devices (AMD).

Company Calendar

Record date for 4/30 Dividend
3/31/2026
Ex-Dividend for 4/30 Dividend
3/31/2026
Last Earnings
4/30/2026
Dividend Payable
4/30/2026
Today
5/07/2026
Bank of America Global Healthcare Conference 2026
5/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:SYK
CIK
310764
Employees
56,000
Year Founded
1941

Price Target and Rating

High Price Target
$465.00
Low Price Target
$315.00
Potential Upside/Downside
+34.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
22 Analysts

Profitability

EPS (Trailing Twelve Months)
$8.64
Trailing P/E Ratio
34.08
Forward P/E Ratio
19.66
P/E Growth
1.84
Net Income
$3.25 billion
Net Margins
13.20%
Pretax Margin
18.20%
Return on Equity
23.42%
Return on Assets
11.04%

Debt

Debt-to-Equity Ratio
0.62
Current Ratio
2.11
Quick Ratio
1.25

Sales & Book Value

Annual Sales
$25.12 billion
Price / Sales
4.49
Cash Flow
$17.01 per share
Price / Cash Flow
17.31
Book Value
$60.00 per share
Price / Book
4.91

Miscellaneous

Outstanding Shares
382,980,000
Free Float
365,367,000
Market Cap
$112.78 billion
Optionable
Optionable
Beta
0.80

Social Links

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NYSE:SYK) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners